ZBIOZenas BioPharma, Inc.

HealthcareUSD
$33.06

The financials

Zenas BioPharma, Inc. by the numbers

For the full year FY2025, revenue was $10M (+100% year on year) and net income −$378M.

Zenas BioPharma, Inc. income statement, Q1 2026 against the same quarter a year earlier
Income statementQ1 2026Q1 2025Change
Revenuen/a$10Mn/a
Operating income−$77M−$37Mn/a
Net income−$81M−$34Mn/a
Diluted EPS−$1.46−$0.80n/a

Biotechnology

Ranks #129 of 145 by Smart Score

Compare peers
SEPN-4.2%
Septerna, Inc.
IMCR+1.8%
Immunocore Holdings plc
AVBP+5.6%
ArriVent BioPharma, Inc.
ARDX-2.1%
Ardelyx, Inc.
MAZE+1.3%
Maze Therapeutics, Inc.
VIR-0.70%
Vir Biotechnology, Inc.